Missing/wrong data?
Log in to edit
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study
scientific article published on 19 August 2013
Author/s
author: Joseph Gligorov, Lesley Fallowfield, Lesley Fallowfield, Ann Knoop, Peter Barrett-Lee, Vladimir Semiglazov, Giuseppe Curigliano
Work details
Publication date
August 19, 2013
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.